Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lloyd Clark

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
American Journal of Ophthalmology|March 18, 2017
ReplyCharles C Wykoff, Ryan T Le, Rahul N Khurana, et al.
American Journal of Ophthalmology|October 6, 2016
Outcomes With As-Needed Aflibercept and Macular Laser Following the Phase III VISTA DME Trial: ENDURANCE 12-Month Extension StudyCharles C Wykoff, Ryan T Le, Rahul N Khurana, et al.
The British Journal of Ophthalmology|August 6, 2017
Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trialCharles C Wykoff, William C Ou, Daniel E Croft, et al.
JAMA Ophthalmology|August 9, 2014
Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trialMegan M Geloneck, Alice Z Chuang, W Lloyd Clark, et al.
American Journal of Ophthalmology|December 11, 2012
Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS studyDavid M Brown, Jeffrey S Heier, W Lloyd Clark, et al.
Ophthalmology. Retina|May 4, 2019
Randomized Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: 2-Year Results of the TREX-AMD StudyCharles C Wykoff, William C Ou, David M Brown, et al.
Ophthalmology|May 7, 2018
Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular EdemaJohn F Payne, W Lloyd Clark, Beau B Bruce, et al.
Ophthalmology. Retina|May 4, 2019
Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: VIEW 1 Extension StudyPeter K Kaiser, Michael Singer, Michael Tolentino, et al.
Ophthalmology|March 24, 2012
Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS studyDavid Boyer, Jeffrey Heier, David M Brown, et al.
Ophthalmology|June 23, 2020
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) ProgramPauline T Merrill, W Lloyd Clark, Alay S Banker, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Ophthalmology|March 18, 2017
ReplyCharles C Wykoff, Ryan T Le, Rahul N Khurana, et al.
American Journal of Ophthalmology|October 6, 2016
Outcomes With As-Needed Aflibercept and Macular Laser Following the Phase III VISTA DME Trial: ENDURANCE 12-Month Extension StudyCharles C Wykoff, Ryan T Le, Rahul N Khurana, et al.
The British Journal of Ophthalmology|August 6, 2017
Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trialCharles C Wykoff, William C Ou, Daniel E Croft, et al.
JAMA Ophthalmology|August 9, 2014
Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trialMegan M Geloneck, Alice Z Chuang, W Lloyd Clark, et al.
American Journal of Ophthalmology|December 11, 2012
Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS studyDavid M Brown, Jeffrey S Heier, W Lloyd Clark, et al.
Ophthalmology. Retina|May 4, 2019
Randomized Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: 2-Year Results of the TREX-AMD StudyCharles C Wykoff, William C Ou, David M Brown, et al.
Ophthalmology|May 7, 2018
Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular EdemaJohn F Payne, W Lloyd Clark, Beau B Bruce, et al.
Ophthalmology. Retina|May 4, 2019
Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: VIEW 1 Extension StudyPeter K Kaiser, Michael Singer, Michael Tolentino, et al.
Ophthalmology|March 24, 2012
Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS studyDavid Boyer, Jeffrey Heier, David M Brown, et al.
Ophthalmology|June 23, 2020
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) ProgramPauline T Merrill, W Lloyd Clark, Alay S Banker, et al.
Pageof 4